From: Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab
Most frequently reported infections in 5 years study population (n = 70 patients) | N (%) |
---|---|
Upper respiratory tract infections (rhinosinusitis, pharyngitis, laryngitis, colds) | 13 (18.6 %) |
Bronchitis/bronchopneumonia | 6 (8.6 %) |
Conjunctivitis eye disorders | 5 (7.1 %) |
Influenza episodes | 4 (5.7 %) |
Diarrhea | 4 (5.7 %) |
Urinary infections | 4 (5.7 %) |
Otitis | 2 (2.8 %) |
Severe skin infections | 2 (2.8 %) |
Dental infections | 2 (2.8 %) |
Vaginitis | 1 (1.4 %) |
Herpes labialis | 1 (1.4 %) |
Tubal ascess | 1 (1.4 %) |